Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EmboCube Embolization Gelatin

K-Number: K181021 · 2018-09-27

Decision Date2018-09-27
Product CodeKRD
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

EmboCube Embolization Gelatin is a medical device manufactured by Biosphere Medical, S.A.. It received FDA 510(k) clearance on 2018-09-27 under approval number K181021. The device is classified under product code KRD. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EmboCube Embolization Gelatin?

EmboCube Embolization Gelatin is a medical device that received FDA 510(k) clearance on 2018-09-27. It is manufactured by Biosphere Medical, S.A.. The 510(k) number is K181021.

When was EmboCube Embolization Gelatin approved by the FDA?

EmboCube Embolization Gelatin received FDA 510(k) clearance on 2018-09-27, under approval number K181021.

What company makes EmboCube Embolization Gelatin?

EmboCube Embolization Gelatin is manufactured by Biosphere Medical, S.A..

What is the FDA product code for EmboCube Embolization Gelatin?

The FDA product code for EmboCube Embolization Gelatin is KRD.

Other Devices by Biosphere Medical, S.A.

View all 8 devices →

Related Devices (Code: KRD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.